Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 840 results for "gilead sciences"

Nasdaq 100 Movers: ISRG, GILD

In early trading on Wednesday, shares of Gilead Sciences (GILD) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.1%. Year to date, Gilead Sciences has lost about 0.9% of its value. And the worst ... Forbes.com, 22 minutes ago

177 images for gilead sciences

American Banking News, 11 hours ago
Jutia Group, 10 hours ago
Business Week, 4 hours ago
San Francisco Chronicle, 8 hours ago
Jutia Group, 1 week ago
Jutia Group, 5 days ago
Bidness Etc, 2 hours ago
CTV News, 2 weeks ago
Live Trading News, 2 weeks ago
Jutia Group, 1 week ago
NBCNews.com

Cramer: Gilead crux of health care in US

Record sales of a new hepatitis C drug pushed the first-quarter earnings of Gilead Sciences beyond expectations. The "Squawk on the Street" news team break down its
 CNBC1 hour ago Sales Of Hepatitis Drug Shatter Records  Kaiser Health News1 hour ago It's official: Gilead's Sovaldi zooms past previous records with fastest-ever drug launch  FiercePharma10 hours ago Video: Cramer: Gilead crux of health care in US  NBCNews.com1 hour ago
Bidness Etc

Gilead Earnings Burn Through Estimates

Gilead Sciences, Inc. ( GILD ) reported earnings results for the first quarter of its fiscal year 2014 (1QFY14), after the market closed. The company, which has been partially blamed for the biotech sell-off that occurred earlier this month, beat ...
 Bidness Etc2 hours ago Gilead Sciences presenta resultados financieros correspondientes al primer trimestre de 2014  Business Wire2 hours ago Gilead Sciences reports higher Q1 net income, reiterates guidance for 2014  Individual.com4 hours ago US FDA accepts Gilead's NDA for cobicistat & elvitegravir for HIV therapy  PharmaBiz5 hours ago
[x]  

Gilead's Medicine Sovaldi Beats Estimates by $1 Billion

(Updates shares trading in fourth paragraph.) April 23 (Bloomberg) -- Gilead Sciences Inc. overwhelmed sales estimates for its new blockbuster hepatitis C pill in what analysts called the biggest drug start ever, raising questions about insurers ...
 Washington Post2 hours ago

Alliance Fiber Optic, Talisman Energy, Gilead Sciences, Biogen Idec and Alexion Pharmaceuticals highlighted …

Zacks Equity Research highlights Alliance Fiber Optic ( AFOP - Free Report ) as the Bull of the Day and Talisman Energy ( TLM - Free Report ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Gilead Sciences Inc. ( ...
 Yahoo! Finance3 hours ago
[x]  

Sovaldi's Q1 Is A Home Run With Men On Base; Why Gilead May Triple From Here

Summary Gilead Sciences is one of the leading growth pharmaceutical companies ever. The company announced an in-line quarter for most of its products, but a monster one for its new product Sovaldi. With a strong pipeline and lots of excess cash ...
 Seeking Alpha2 hours ago
Business Week

Gilead Sales Double on $1,000 Hepatitis C Pills

Sovaldi sales soared in the first quarter for Gilead Sciences despite criticism over the high cost of the new therapy
 Business Week4 hours ago
Bloomberg

Today's Health Care Stocks to Watch: Illumina Inc., Intuitive Surgical Inc. and Gilead Sciences

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Illumina ( NASDAQ: ILMN ) , Intuitive Surgical, ( NASDAQ: ISRG ) and Gilead Sciences ( NASDAQ: GILD ) . First quarter earnings could drive Illumina ...
 Motley Fool2 hours ago Health Care Stocks' Vitals Still Look Good  Bloomberg1 day ago
Zacks.com

Strong Q1 Earnings at Gilead on Stellar Sovaldi Sales

Gilead Sciences, Inc. ( GILD ) made a strong start to 2014, with both revenues as well as earnings beating expectations by huge margins in the first quarter of the year. The company's first-quarter 2014 earnings (including stock-based compensation ...
 Yahoo! Finance6 minutes ago Stocks: Waiting for big tech earnings  Channel40006 hours ago Biotech Earnings Preview  Motley Fool21 hours ago Flood of earnings leads calendar  Yahoo! Finance1 day ago
[x]  
Motley Fool

Say Hello to the New Fastest Growing Drug in History!

Take every guess you had as to how well Gilead Sciences ( NASDAQ: GILD ) would perform in the first-quarter, no matter how outrageous, and completely throw them out the window because Gilead would have trumped it! Break out your thesaurus ...
 Motley Fool1 hour ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less